-
The Network
-
The Vanguard Study
Latest News and Initiatives
-
NCI Selects Two Assays for the Vanguard Study on Multi-Cancer Detection TestsNCI has selected two assays to be included in the Vanguard Study on multi-cancer detection (MCD) tests which will be conducted by the CSRN.
-
NCI Virtual Workshop to Engage Multi-Cancer Detection Assay DevelopersPresenters: Lori Minasian, M.D.; Elyse LeeVan, M.D.; Amanda Skarlupka, Ph.D; Marie Wood, M.D.
-
Questions and Answers about Multi-Cancer Detection TestsAbout Cancer Screening, About Multi-Cancer Detection Tests, and Risks, Benefits, and Needed Research
Contact CSRN
Email: CSRN@nih.gov
Fred Hutch Cancer Center
The Fred Hutch Cancer Center leads the CSRN multi-center effort to examine the effectiveness of emerging technologies for cancer screening.
Look for this badge at participating Program organizations and institutions. It means they have been awarded a grant by the National Cancer Institute (NCI) as a member of the Cancer Screening Research Network (CSRN).